43
Views
4
CrossRef citations to date
0
Altmetric
Commentary

Cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab: prophylaxis vs. pre-emptive strategies for prevention

&
Pages 2435-2436 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carlos Vallejo, Eduardo Ríos, Javier de la Serna, Isidro Jarque, Christelle Ferrá, Pedro Sánchez-Godoy, Carlos Solano, Rafael de la Cámara, Ana Isabel Rosell, Rosario Varela, María Dolores García, Eva González-Barca, Javier López, Elena Pérez, Secundino Ferrer, Luis Felipe Casado, Lourdes Vázquez, Lucía Villalón & José A García-Marco. (2011) Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab. Expert Review of Hematology 4:1, pages 9-16.
Read now

Articles from other publishers (3)

Morgan Hakki, Per Ljungman & Michael Boeckh. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 341 358 .
Lesia K. Dropulic & Howard M. Lederman. 2008. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host 1 43 .
P Ljungman, R de la Camara, C Cordonnier, H Einsele, D Engelhard, P Reusser, J Styczynski & K Ward. (2008) Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplantation 42:4, pages 227-240.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.